Modified Type A DNA Polymerases for Industrial Enzymatic Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

DNA polymerases used in industrial and research applications often face challenges due to environmental differences from their natural cellular environment, leading to suboptimal performance in terms of activity, fidelity, and stability.

Innovation Solution

Modified type A DNA polymerases with specific amino acid alterations at positions such as P6, K53, K56, E57, and others are developed through directed evolution to enhance enzyme activity, fidelity, processivity, and stability, making them better suited for recombinant DNA technologies.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If DNA polymerases are used in industrial or research applications, then they can perform DNA synthesis and amplification, but their performance deteriorates due to environmental differences from their natural cellular environment

Engineering Contradiction:
Improveenzyme performanceVSAvoidenvironmental adaptation
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent applies parameter changes by systematically modifying amino acid residues at specific positions (P6, K53, K56, E57, K171, T203, E209, D238, L294, V310, G364, E400, A414, E507, S515, E742, E797) to adapt the DNA polymerase to non-natural environments. These parameter changes in the protein structure enable the enzyme to maintain optimal performance in industrial and research applications despite environmental differences from its natural cellular context.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If DNA polymerases are adapted to natural cellular environment, then they function efficiently in vivo, but their performance deteriorates in industrial or research applications with different conditions

Engineering Contradiction:
Improveenzyme activityVSAvoidperformance consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies local quality by making specific localized modifications at particular amino acid positions within the DNA polymerase structure. Instead of uniformly modifying the entire enzyme, targeted mutations at specific residues (such as E507K, D238N, L294P) are introduced to locally alter properties that affect performance in industrial and research applications while preserving overall enzyme function.

Inventive Principle:
Principle #3Local quality

3Productivity

If amino acid alterations are introduced to improve enzyme activity, then polymerization efficiency increases, but fidelity and stability may be compromised

Engineering Contradiction:
Improvepolymerization efficiencyVSAvoidfidelity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent applies dynamics by creating a balanced system where multiple amino acid alterations work together to dynamically optimize enzyme properties. The combination of mutations at various positions (e.g., E507K for activity, D238N for fidelity, L294P for stability) creates a synergistic effect that simultaneously improves polymerization efficiency while maintaining or enhancing fidelity and stability through coordinated structural changes.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS11603547B2Modified type A DNA polymerases
Publication Date: 2023.03.14 KAPA BIOSYSTEMS INC
  • US11603547B2 patent drawing
  • US11603547B2 patent drawing

AI summary

The present invention provides improved DNA polymerases, in particular, type A DNA polymerases, that may be better suited for applications in recombinant DNA technologies. Among other things, the present invention provides modified DNA polymerases derived from directed evolution experiments designed to select mutations that confer advantageous phenotypes under conditions used in industrial or research applications.